CDK9-IN-34 (Compound 1b) is an inhibitor for CDK9 with an IC50 of 0.25 µM. CDK9-IN-34 exhibits cytotoxicity to cancer cell HCT116, MCF7 and K652 with IC50s of 1.43, 3.01 and 50.27 µM, respectively. CDK9-IN-34 exhibits antiviral activity against coronavirus 229E with an IC50 of 145.92 µM[1].
Molecular Weight:
292.38
Purity:
99.82
CAS Number:
[252725-86-3]
Formula:
C18H20N4
Target:
CDK,SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
